Ilan S. Schwartz
Cited by
Cited by
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ...
New England Journal of Medicine, 2020
Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial
CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ...
Annals of internal medicine 173 (8), 623-631, 2020
Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)
KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ...
Open Forum Infectious Diseases 7 (4), ofaa130, 2020
Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales)
K Dukik, JF Muņoz, Y Jiang, P Feng, L Sigler, JB Stielow, J Freeke, ...
Mycoses 60 (5), 296-309, 2017
Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series
IS Schwartz, NP Govender, C Corcoran, S Dlamini, H Prozesky, R Burton, ...
Clinical Infectious Diseases 61 (6), 1004-1012, 2015
Emerging fungal infections: New patients, new patterns, and new pathogens
DZP Friedman, IS Schwartz
Journal of Fungi 5 (3), 67, 2019
50 Years of Emmonsia Disease in Humans: The Dramatic Emergence of a Cluster of Novel Fungal Pathogens
IS Schwartz, C Kenyon, P Feng, NP Govender, K Dukik, L Sigler, Y Jiang, ...
PLoS pathogens 11 (11), e1005198, 2015
Outbreak Detection: First reported case of multidrug-resistant Candida auris in Canada
IS Schwartz, GW Hammond
Canada Communicable Disease Report 43 (7-8), 150, 2017
Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis
Y Jiang, K Dukik, JF Muņoz, L Sigler, IS Schwartz, NP Govender, ...
Fungal Diversity 90 (1), 245-291, 2018
Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States
IS Schwartz, NP Wiederhold, KE Hanson, TF Patterson, L Sigler
Clinical Infectious Diseases 68 (2), 188-195, 2019
In vitro antifungal susceptibility of yeast and mold phases of isolates of dimorphic fungal pathogen Emergomyces africanus (formerly Emmonsia sp.) from HIV-infected South …
TG Maphanga, E Britz, TG Zulu, RS Mpembe, SD Naicker, IS Schwartz, ...
Journal of clinical microbiology 55 (6), 1812-1820, 2017
Effects of sexual network connectivity and antimicrobial drug use on antimicrobial resistance in Neisseria gonorrhoeae
CR Kenyon, IS Schwartz
Emerging infectious diseases 24 (7), 1195, 2018
AIDS-related endemic mycoses in Western Cape, South Africa, and clinical mimics: a cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions
IS Schwartz, C Kenyon, R Lehloenya, S Claasens, Z Spengane, ...
Open forum infectious diseases 4 (4), ofx186, 2017
Emergomyces canadensis, a dimorphic fungus causing fatal systemic human disease in North America
IS Schwartz, S Sanche, NP Wiederhold, TF Patterson, L Sigler
Emerging infectious diseases 24 (4), 758, 2018
High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta, Canada
IS Schwartz, DZP Friedman, L Zapernick, TC Dingle, N Lee, W Sligl, ...
Clinical Infectious Diseases, 2020
The emerging threat of antifungal resistance in transplant infectious diseases
IS Schwartz, TF Patterson
Current infectious disease reports 20 (3), 2, 2018
HIV prevalence correlates with high-risk sexual behavior in Ethiopia's regions
CR Kenyon, A Tsoumanis, IS Schwartz
PloS one 10 (10), e0140835, 2015
Partner concurrency and HIV infection risk in South Africa
CR Kenyon, A Tsoumanis, IS Schwartz, B Maughan-Brown
International Journal of Infectious Diseases 45, 81-87, 2016
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial
SA Lother, M Abassi, A Agostinis, AS Bangdiwala, MP Cheng, G Drobot, ...
Canadian Journal of Anaesthesia, 1, 2020
Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19
SM Lofgren, MR Nicol, AS Bangdiwala, KA Pastick, EC Okafor, ...
Open forum infectious diseases 7 (11), ofaa500, 2020
The system can't perform the operation now. Try again later.
Articles 1–20